Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-018977
Filing Date
2024-04-29
Accepted
2024-04-29 16:03:57
Documents
4
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A fy2023def14aproxystatement.htm DEF 14A 510664
2 image_0a.jpg GRAPHIC 6694
3 proxycard1a.jpg GRAPHIC 109253
4 proxycard2a.jpg GRAPHIC 86936
  Complete submission text file 0001628280-24-018977.txt   791412
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41536 | Film No.: 24890543
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)